Community voting is open to everyone. Members vote once per account, qualify for prizes, and see a members-only tally that is a cleaner signal.
Probiful
Log inSign up
Markets
Predict healthcare events for bragging rights
Sort
Closing soonTrendingNew50-50
Category
AllDrug pricingRegulatoryPolicyOther
Tags
AllFDALaunch pricePDUFAWACCingulateSummit TherapeuticsReplimuneAchieve Life SciencesEton PharmaceuticalsShionogiGrace Therapeutics
ET-600 (desmopressin oral solution) monthly WAC at launch?
$600–$700
70%
Yes/No
≥ $2k
50%
Yes/No
Vote on range
Community vote80% Yes · 5 votes
Vote
50 vol
Locks Mar 27, 2026
RP1 (vusolimogene oderparepvec) + nivolumab monthly WAC at launch?
≥ $505k
50%
Yes/No
$480k–$505k
50%
Yes/No
Vote on range
Community vote63% Yes · 8 votes
Vote
0 vol
Locks May 10, 2026
GTx-104 (nimodipine formulation) monthly WAC at launch?
≥ $50k
50%
Yes/No
$45k–$50k
50%
Yes/No
Vote on range
Community vote50% Yes · 4 votes
Vote
0 vol
Locks May 23, 2026
CTx-1301 (dexmethylphenidate) monthly WAC at launch?
≥ $126k
50%
Yes/No
$121k–$126k
50%
Yes/No
Vote on range
Community vote100% Yes · 1 votes
Vote
0 vol
Locks Jun 30, 2026
Ensitrelvir (ensitrelvir fumaric acid; S-217622) monthly WAC at launch?
≥ $5k
50%
Yes/No
$4.8k–$5k
50%
Yes/No
Vote on range
Community vote100% Yes · 1 votes
Vote
0 vol
Locks Jul 16, 2026
Cytisinicline monthly WAC at launch?
≥ $2k
50%
Yes/No
$1.9k–$2k
50%
Yes/No
Vote on range
Community vote67% Yes · 3 votes
Vote
0 vol
Locks Jul 20, 2026
Ivonescimab + chemotherapy monthly WAC at launch?
≥ $126k
50%
Yes/No
$121k–$126k
50%
Yes/No
Vote on range
Community vote50% Yes · 0 votes
Vote
0 vol
Locks Jan 30, 2027